Jacobs Levy Equity Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22M Buy
1,004,798
+339,447
+51% +$411K ﹤0.01% 721
2025
Q1
$845K Buy
665,351
+99,447
+18% +$126K ﹤0.01% 843
2024
Q4
$1.84M Sell
565,904
-424
-0.1% -$1.38K 0.01% 605
2024
Q3
$1.86M Buy
566,328
+147,438
+35% +$485K 0.01% 619
2024
Q2
$1.78M Buy
418,890
+270,872
+183% +$1.15M 0.01% 624
2024
Q1
$2.18M Buy
148,018
+33,039
+29% +$486K 0.01% 580
2023
Q4
$1.11M Sell
114,979
-284,505
-71% -$2.74M 0.01% 698
2023
Q3
$1.86M Sell
399,484
-5,502
-1% -$25.6K 0.01% 570
2023
Q2
$2.17M Buy
404,986
+100,864
+33% +$540K 0.01% 547
2023
Q1
$2.18M Buy
304,122
+248,386
+446% +$1.78M 0.01% 557
2022
Q4
$374K Buy
+55,736
New +$374K ﹤0.01% 834
2022
Q3
Sell
-71,224
Closed -$210K 1107
2022
Q2
$210K Sell
71,224
-97,000
-58% -$286K ﹤0.01% 955
2022
Q1
$1.48M Buy
+168,224
New +$1.48M 0.01% 683
2020
Q4
Sell
-18,484
Closed -$466K 1064
2020
Q3
$466K Sell
18,484
-192,152
-91% -$4.84M ﹤0.01% 807
2020
Q2
$5.88M Sell
210,636
-11,809
-5% -$330K 0.06% 305
2020
Q1
$1.3M Buy
+222,445
New +$1.3M 0.02% 572
2019
Q2
Sell
-34,300
Closed -$617K 995
2019
Q1
$617K Sell
34,300
-108,566
-76% -$1.95M 0.01% 749
2018
Q4
$1.81M Buy
142,866
+5,000
+4% +$63.5K 0.03% 476
2018
Q3
$2.96M Sell
137,866
-11,304
-8% -$242K 0.04% 430
2018
Q2
$3.08M Buy
149,170
+28,273
+23% +$584K 0.05% 409
2018
Q1
$3.04M Sell
120,897
-27,139
-18% -$683K 0.05% 387
2017
Q4
$2.81M Buy
148,036
+74,485
+101% +$1.42M 0.05% 392
2017
Q3
$1.36M Buy
73,551
+54,161
+279% +$1M 0.03% 524
2017
Q2
$340K Sell
19,390
-86,060
-82% -$1.51M 0.01% 755
2017
Q1
$1.96M Buy
105,450
+84,250
+397% +$1.57M 0.04% 430
2016
Q4
$433K Buy
+21,200
New +$433K 0.01% 705
2016
Q3
Sell
-53,817
Closed -$1.45M 1087
2016
Q2
$1.45M Sell
53,817
-29,140
-35% -$787K 0.03% 489
2016
Q1
$1.56M Buy
+82,957
New +$1.56M 0.03% 467